Direct to Production

Process (D2P)
Change and Release
Management (C&RM)
GA&D Tech

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 1
BUS-PAP-775
 Receiving credit for completing this module
To receive credit for completing this module, you are required to review and understand all of the content contained within the module.
Instructional text will inform you of the actions you must take on each page. These actions include, but are not limited to, clicking every tab,
clicking every button that opens a pop-up.
You are required to read section 2.2 of SOP_645278 only.
At the end of this module, you will be given an opportunity to mark the module complete. By marking this module complete, you acknowledge
that you have reviewed and understand all of the content contained within this module.

It will take you approximately 15 minutes to complete this module.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 2
BUS-PAP-775
 Scope of the training

The scope of this training  The

BuildChange
upon lastManagement
POA of Unless
 Plan a documented
for and implement a
covers the Direct to process
short callissales
applicable to all exception
call or alternate
continuum with
Production process for changes being made to the
effectiveness approved with
customers procedure
whom exists,
you
‘Single Track landscape’ Single Track landscape that this procedure
have limited time applies to all
only. are managed by Global changes for Support and
This process is applicable to Applications and Projects.
those changes that cannot Development (GA&D Tech).
be transports through the
landscape.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 3
BUS-PAP-775
 Process flow
Direct to Production (D2P)

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 4
BUS-PAP-775
 C&RM D2P process flow – high level
3. Approve D2P form

4. Request FF access (if applicable)

1. Request 2. Draft D2P 5. Execute D2P deploy plan

RT via 1SS form

6. FF owner review/approval of logs (if

applicable)

7. Inform C&RM of implemented date

8. Sign “True Copy” (if where applicable)

9. C&RM close

Process end

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 5
BUS-PAP-775
 C&RM process flow – high level
RETURN

Request RT via 1SS (1 of 9) Complete verification testing

• Move
Request Change Control Number using RT (Rev-Trac to Informal
Request) & Testrequest template from the
number
1SS*
Request Approve Development to Quality form
Start
RT via (D2Q) to move to Formal
Build
•1SSIf the Risk Assessment is known at this time ensure it is provided to Change Management Team
• Email request to C&RM mailbox Execute formal Testing

• Approve
An automatic mail notification is generated to QualityOwner
the Change to Production form (Q2P)upon creation by
from Rev-Trac
to move to Production
C&RM

*Copy and paste this link in to your browser Change

Change caused issue deployed inc.
https://myconnect.gsk.com/sites/sap/CRM/
(return to step 2) manual
Process End
changes

Tap/click eachthe
Tap/Click Step to learn
Return abouttoitclose
button in detail.
this pop-up.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 6
BUS-PAP-775
 C&RM process flow – high level
RETURN

Draft D2P form (2 of 9) Complete verification testing

• Move to Informalif&applicable
Start to draft D2P and create/update any impacted documentation Test (TIP, Dataload Plan
etc)
Request Approve Development to Quality form
Start
RT via (D2Q) to move to Formal
Build
•1SSIf using FF, the intent to use it must be documented in the D2P from
Execute formal Testing

Approve Quality to Production form (Q2P)

to move to Production

Change
Change caused issue deployed inc.
Process End
(return to step 2) manual
changes

Tap/click eachthe
Tap/Click Step to learn
Return abouttoitclose
button in detail.
this pop-up.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 7
BUS-PAP-775
 C&RM process flow – high level
RETURN

Approve D2P form (3 of 9) Complete verification testing

• Move to Informal & Test

Complete D2P form detailing the scope of the change

Request Approve Development to Quality form

RT The Risk AssessmentStart
• via must be provided to C&RM team;
(D2Q)for guidance,
to move refer to the Risk Assessment
to Formal
Build
1SSguidance on the QRC 1SS

Execute formal Testing

Approve Quality to Production form (Q2P)

to move to Production

Change
Change caused issue deployed inc.
Process End
(return to step 2) manual
changes

Tap/click eachthe
Tap/Click Step to learn
Return abouttoitclose
button in detail.
this pop-up.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 8
BUS-PAP-775
 C&RM process flow – high level
RETURN

Request FF access if applicable (4 of 9) Complete verification testing

• If requesting FF access, refer to SOP0431155 - ERPMove

LSOP to for
Informal & Test Usage and Monitoring -
Firefighter
GRC 10.0 Emergency Access Management
Request Approve Development to Quality form
Start
RT via (D2Q) to move to Formal
Build
1SS

Execute formal Testing

Approve Quality to Production form (Q2P)

to move to Production

Change
Change caused issue deployed inc.
Process End
(return to step 2) manual
changes

Tap/click eachthe
Tap/Click Step to learn
Return abouttoitclose
button in detail.
this pop-up.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 9
BUS-PAP-775
 C&RM process flow – high level
RETURN

Execute D2P deploy plan (5 of 9) Complete verification testing

Move to Informal & Test

• Once the D2P is approved, if FF/CCID is required but not listed in D2P, the D2P must be up-
versioned. This cannot be managed as a deviation
Request Approve Development to Quality form
Start
RT via (D2Q) to move to Formal
Build
1SS
• If an extension to a FF/CCID is required, this can be managed as a deviation. This must be typed up
not handwritten Execute formal Testing

Approve Quality to Production form (Q2P)

to move to Production

Change
Change caused issue deployed inc.
Process End
(return to step 2) manual
changes

Tap/click eachthe
Tap/Click Step to learn
Return abouttoitclose
button in detail.
this pop-up.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 10
BUS-PAP-775
 C&RM process flow – high level
RETURN

FF Owner review/approval of logs (6 of 9) Complete verification testing

Moveand
• Refer to SOP0431155 - ERP LSOP for Firefighter Usage to Informal & Test- GRC 10.0 Emergency
Monitoring
Access Management
Request Approve Development to Quality form
Start
RT via (D2Q) to move to Formal
Build
1SS

Execute formal Testing

Approve Quality to Production form (Q2P)

to move to Production

Change
Change caused issue deployed inc.
Process End
(return to step 2) manual
changes

Tap/click eachthe
Tap/Click Step to learn
Return abouttoitclose
button in detail.
this pop-up.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 11
BUS-PAP-775
 C&RM process flow – high level
RETURN

Inform C&RM of implemented date (7 of 9) Complete verification testing

• Where FireFighter (FF) has been used, once the FF Move

Ownerto has
Informal & Test the FF logs in GRC, email
approved
C&RM mailbox to inform them of the implemented date so they process the change
Request Approve Development to Quality form
Start
RT via (D2Q) to move to Formal
Build
1SS

Execute formal Testing

Approve Quality to Production form (Q2P)

to move to Production

Change
Change caused issue deployed inc.
Process End
(return to step 2) manual
changes

Tap/click eachthe
Tap/Click Step to learn
Return abouttoitclose
button in detail.
this pop-up.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 12
BUS-PAP-775
 C&RM process flow – high level
RETURN

Complete
For High GxP changes only – Sign “True Copy” step (8 of verification
9) testing

• If you have provided C&RM with any exhibits you areMove to Informal
required & Test
to verify this step in Rev-Trac

Request Approve Development to Quality form

Start
RT via (D2Q) to move to Formal
Build
1SS

Execute formal Testing

Approve Quality to Production form (Q2P)

to move to Production

Change
Change caused issue deployed inc.
Process End
(return to step 2) manual
changes

Tap/click eachthe
Tap/Click Step to learn
Return abouttoitclose
button in detail.
this pop-up.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 13
BUS-PAP-775
 C&RM process flow – high level
RETURN

C&RM Close RT (9 of 9) Complete verification testing

• Change is set to COMP Move to Informal & Test

Request Approve Development to Quality form

Start
RT via (D2Q) to move to Formal
Build
1SS

Execute formal Testing

Approve Quality to Production form (Q2P)

to move to Production

Change
Change caused issue deployed inc.
Process End
(return to step 2) manual
changes

Tap/click eachthe
Tap/Click Step to learn
Return abouttoitclose
button in detail.
this pop-up.

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 14
BUS-PAP-775
 Summary

You have reached the end of this learning programme and

should now be able to:

Manage a Change Control using the Direct to Production

process

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 15
BUS-PAP-775
 Mark complete

• You have completed this course. To review any of the information in this presentation, tap/click on the topic from the
menu list .
• After completion of the module, please tap/click the Mark complete button below to mark this module complete.
• By marking complete, you acknowledge that you have reviewed and understand all of the content contained within this
module. The module content may have included, but is not limited to, tabs, pop-ups, interactive exercises and
attachments.
• After marking this module complete, tap/click the NEXT button to advance to the survey page.

Mark complete

Change and Release Management (C&RM) Confidential - For GSK internal training only.
These materials may not be shown to customers. Tap/Click the NEXT button to advance to the next page. 16
BUS-PAP-775